NCT00612430 2013-08-12Ph II Bevacizumab + Etoposide for Pts w Recurrent MGDuke UniversityPhase 2 Completed59 enrolled 10 charts
NCT00613028 2013-07-16Ph II Bev + Either Temozolomide/Etoposide for GBM Pts Who Have Failed Bev + IrinotecanDuke UniversityPhase 2 Completed23 enrolled 10 charts